Acceder
  1. Inicio
  2. Perfil de Pasiego del Pas
  3. Contenidos recomendados por Pasiego del Pas

Contenidos recomendados por Pasiego del Pas

Pasiego del Pas 23/11/20 23:46
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
Hoy en el telediario de A3 del mediodía han hablado de las 7 vacunas que tienen contrato con Europa. Textualmente “ la Unión Europea tiene ahora mismo contrato con estas 7 farmacéuticas que tienen en imagen” 
Ir a respuesta
Pasiego del Pas 03/10/20 13:07
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
Will Big Pharma Acquire Novavax?Me acuerdo que, en el 2015/16 uno de los temas principales de conversación en el Chat era que big pharma iba a hacer el BO sobre nvax. En este último año ha sido un tema casi tabú.https://www.fool.com/investing/2020/10/03/will-big-pharma-acquire-novavax/
Ir a respuesta
Pasiego del Pas 26/09/20 09:55
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
La vacuna anticovid de Johnson & Johnson produce una fuerte respuesta inmune, según resultados preliminareshttps://www.elmundo.es/ciencia-y-salud/salud/2020/09/25/5f6e4c38fc6c83b0298b4581.html
Ir a respuesta
Pasiego del Pas 03/09/20 11:13
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
El artículo dice que NVAX está fabricando en España. ¿Alguien sabe que empresa es?Novavax also has agreements with three FUJI-FILM facilities in the US and the UK to provide Novavax with capacity for up to 700 million doses as needed from those facilities. The top pharma company in Japan (with funding from the Japanese government) has agreed to manufacture and sell 250 million doses in Japan. A major vaccine manufacturer in South Korea has also agreed to manufacture doses that I estimate at 250 million doses. Novavax also is manufacturing in Spain. It's manufacturing in 7 countries in all.
Ir a respuesta
Pasiego del Pas 10/08/20 22:23
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
Manufacturing of Novavax' Matrix-M™Adjuvant for Novel COVID-19 Vaccine Expands to SeattleSEATTLE, Aug. 10, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it has expanded its partnership with Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases. AGC Biologics is currently preparing to manufacture Matrix-M™, the adjuvant component of Novavax' coronavirus vaccine, NVX-CoV2373, from its facility in Copenhagen. AGC Biologics will now expand supply of Matrix-M adjuvant for the vaccine from its facility in Seattle to ensure supply for the United States.https://finance.yahoo.com/news/agc-biologics-expands-partnership-novavax-200500193.html?_guc_consent_skip=1597090921
Ir a respuesta
Pasiego del Pas 10/08/20 22:20
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
Announced Positive Phase 1 data of Phase 1/2 clinical trial of NVX-CoV2373Secured $2 billion in funding for global coronavirus vaccine program through CEPI, DoD, and OWSExpanded large scale global manufacturing capacity through acquisition and partneringCompany to host conference call today at 4:30 p.m. ETNovavax reported a net loss of $17.5 million, or $0.30 per share, for the second quarter of 2020, compared to a net loss of $39.6 million, or $1.69 per share, for the second quarter of 2019. For the six months ended June 30, 2020, the net loss was $43.4 million, or $0.84 per share, compared to a net loss of $82.8 million, or $3.77 per share, for the same period in 2019.Novavax revenue in the second quarter of 2020 was $35.5 million, compared to $3.4 million in the same period in 2019. This significant increase was due to increased development activities relating to NVX-CoV2373 under the CEPI agreement.https://finance.yahoo.com/news/novavax-reports-second-quarter-2020-200200678.html?_guc_consent_skip=1597090664
Ir a respuesta
Pasiego del Pas 05/08/20 16:39
Ha respondido al tema Farmas USA
- Government of Canada will support advancement of VBI’s coronavirus program through Phase 2 clinical development- Pre-clinical data are expected to enable selection of clinical candidates in Q3 2020 and the initiation of clinical studies by the end of 2020https://finance.yahoo.com/news/vbi-vaccines-awarded-cad-56-130000637.html?_guc_consent_skip=1596638270VBIV
Ir a respuesta
Pasiego del Pas 16/07/20 10:12
Ha respondido al tema Farmas USA
El valor de la vacuna anticovid: el directivo español de Moderna ya ha hecho caja por 7 Mhttps://www.elconfidencial.com/mercados/2020-07-16/valor-vacuna-acciones-directivo-moderna_2683648/MRNA
Ir a respuesta
Pasiego del Pas 10/06/20 13:13
Ha respondido al tema Farmas USA
Vuelve Beño al ataqueeeeerrrrrr...https://inbestia.com/analisis/el-covid19-ya-es-historia-vuelta-en-v-por-pocos-pronosticada-y-ahora-viene-el-futuro
Ir a respuesta